J&J Seals $30 Billion Actelion Deal to Enter Rare Disease Arena – Bloomberg | International News Live Blog

https://internationalnewsliveblog.wordpress.com/2017/01/26/jj-seals-30-billion-actelion-deal-to-enter-rare-disease-arena-bloomberg/

BloombergJ&J Seals $30 Billion Actelion Deal to Enter Rare Disease ArenaBloombergJohnson & Johnson agreed to buy Actelion Ltd. for $30 billion and spin off the Swiss drugmaker's research and development operations, clinching its largest deal ever to become a leader in medicines treating a rare type of high … http://internationalnewslive.com/jj-seals-30-billion-actelion-deal-to-enter-rare-disease-arena-bloomberg/